Purchases and Sales Made in Q4 2024 in Prelude Therapeutics Inc (PRLD)
This table provides information about the institutional ownership of Prelude Therapeutics Inc (PRLD) during Q4 2024. The information is specifically focused on institutions that hold shares of Prelude Therapeutics Inc.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Jan 30, 2025
Q4 2024
|
Rhumbline Advisers
Boston, MA |
BUY
|
- |
155K+ 1289.79% |
$124K - $316K
|
167K
$195K
|
|
Feb 05, 2025
Q4 2024
|
Sbi Securities Co., Ltd.
Tokyo, M0 |
BUY
|
- |
2.74KNew |
$2.19K - $5.59K
|
2.74K
$3.21K
|
|
Feb 04, 2025
Q4 2024
|
Cwm, LLC
|
BUY
|
- |
1.89K+ 18890.0% |
$1.51K - $3.85K
|
1.9K
$2.22K
|
|
Jan 17, 2025
Q4 2024
|
Nisa Investment Advisors, LLC
|
BUY
|
- |
508New |
$406 - $1.04K
|
508
$594
|
|
Feb 06, 2025
Q4 2024
|
Charles Schwab Investment Management Inc
San Francisco, CA |
SELL
|
- |
-16K- 12.04% |
$12.8K - $32.7K
|
117K
$137K
|